Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for prevention of acute anthracycline-induced cardiomyopathy
IRCT2016121213090N3Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rosuvastatin in Cardiomyopathies, sponsored by Mazandaran University of Medical Sciences. Started Jan 2017; status: completed.
02
Drugs
rosuvastatin
03
Conditions
Cardiomyopathies
Beyond the preview
Go deeper on IRCT2016121213090N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016121213090N3.